Twist Bioscience Corporation
TWST
株式のランク
#2145
Twist Bioscience Corporation operates as a leading synthetic biology firm,... Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
株価
$144.87
最終同期: 2026-10-20
時価総額
$9.54B
変化（1日）
3.65%
変化（1年）
333.86%
国
US
取引 Twist Bioscience Corporation (TWST)
カテゴリー
Healthcare
Twist Bioscience Corporation（TWST）の発行済株式数
June 2026 時点の発行済株式数 62.40M
Twist Bioscience Corporation の最新の財務報告および株価によると、現在の発行済株式数は 62.40M です。September 2024 の終わりには、同社は 58.02M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Twist Bioscience Corporation（TWST）の発行済株式数の履歴（2016 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 62.40M | 4.34% |
| 2025 | 59.81M | 3.09% |
| 2024 | 58.02M | 1.99% |
| 2023 | 56.89M | 5.57% |
| 2022 | 53.89M | 11.68% |
| 2021 | 48.25M | 23.12% |
| 2020 | 39.19M | 42.71% |
| 2019 | 27.46M | 3.20% |
| 2018 | 26.61M | 41.69% |
| 2017 | 18.78M | 0.00% |
| 2016 | 18.78M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 371.00M | 494.52% |
US
|
|
| 705.30M | 1,030.23% |
US
|
|
| 143.28M | 129.60% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 351.90% |
US
|
